A

Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS

Watchlist Manager
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Watchlist
Price: 514.3 INR -4.67% Market Closed
Market Cap: ₹78.7B

Akums Drugs and Pharmaceuticals Ltd
Other Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Akums Drugs and Pharmaceuticals Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
A
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Other Operating Expenses
-₹558.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Other Operating Expenses
-₹15.6B
CAGR 3-Years
-6%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Other Operating Expenses
-₹7.4B
CAGR 3-Years
-14%
CAGR 5-Years
-17%
CAGR 10-Years
-16%
O
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
Other Operating Expenses
-₹6.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sai Life Sciences Ltd
NSE:SAILIFE
Other Operating Expenses
-₹1.3m
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Anthem Biosciences Ltd
NSE:ANTHEM
Other Operating Expenses
-₹553.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Akums Drugs and Pharmaceuticals Ltd
Glance View

Akums Drugs and Pharmaceuticals Ltd., an unsung hero within India's healthcare sector, crafts its narrative through a robust commitment to pharmaceutical manufacturing. Founded in 2004, this company quietly emerged as a formidable provider of contract drug manufacturing solutions. Instead of marketing its own branded products, Akums positions itself as the silent partner behind many well-known pharmaceutical names, providing vital production services. By offering end-to-end manufacturing, from raw material sourcing to finished product packaging, Akums ensures that pharmaceutical companies can concentrate on their strengths: marketing and distribution. The company thrives on its vast portfolio, which encompasses the manufacture of nearly every form of a pharmaceutical product—be it tablets, capsules, injectables, or topical treatments. Akums drives revenue through partnerships, where it functions as the backbone of production lines for its clients. Utilizing cutting-edge technology and stringent global standards, Akums not only addresses the varied needs of the pharmaceutical industry but also adapts to the ever-evolving demands of healthcare worldwide. This strategic focus on high-quality contract manufacturing fuels its financial success, allowing it to expand facilities and scale operations, while maintaining a discreet presence that underscores its core philosophy: to innovate in service rather than spotlight.

AKUMS Intrinsic Value
479.02 INR
Overvaluation 7%
Intrinsic Value
Price ₹514.3
A

See Also

What is Akums Drugs and Pharmaceuticals Ltd's Other Operating Expenses?
Other Operating Expenses
-558.7m INR

Based on the financial report for Mar 31, 2025, Akums Drugs and Pharmaceuticals Ltd's Other Operating Expenses amounts to -558.7m INR.

What is Akums Drugs and Pharmaceuticals Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 1Y
6%

Over the last year, the Other Operating Expenses growth was 6%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett